Nasal oxytocin for the treatment of psychiatric disorders and pain: achieving meaningful brain concentrations
Abstract There is evidence of the therapeutic potential of intranasal oxytocin for the treatment of pain and various psychiatric disorders, however, there is scant evidence that oxytocin reaches the brain. We quantified the concentration and distribution pattern of [125I]-radiolabeled oxytocin in th...
Main Authors: | David C. Yeomans, Leah R. Hanson, Dean S. Carson, Brendan J. Tunstall, Mary R. Lee, Alexander Z. Tzabazis, Daniel Jacobs, William H. Frey |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-07-01
|
Series: | Translational Psychiatry |
Online Access: | https://doi.org/10.1038/s41398-021-01511-7 |
Similar Items
-
Intranasal Administration for Pain: Oxytocin and Other Polypeptides
by: Vimala N. Bharadwaj, et al.
Published: (2021-07-01) -
Oxytocin and Psychiatric Disorders
by: Gokce Nur Say, et al.
Published: (2016-06-01) -
Increased Serum and Urinary Oxytocin Concentrations after Nasal Administration in Beagle Dogs
by: Andrea Temesi, et al.
Published: (2017-09-01) -
Oxytocin enhances observational fear in mice
by: Marc T. Pisansky, et al.
Published: (2017-12-01) -
Brief communication: Plasma cortisol concentration is affected by lactation, but not intra-nasal oxytocin treatment, in beef cows.
by: Brooklyn K Wagner, et al.
Published: (2021-01-01)